Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000052357 |
|---|---|
| Receipt number | R000059742 |
| Scientific Title | Effect of Injection Site Pain in Patients Receiving Romosozumab for Osteoporosis |
| Date of disclosure of the study information | 2023/11/01 |
| Last modified on | 2025/11/11 10:29:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2023/09/30 10:39:02 | ||
| 2 | Update | 2023/09/30 10:40:01 | Public title |
|
| 3 | Update | 2023/10/01 14:18:39 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 4 | Update | 2024/03/26 05:16:03 | Key inclusion criteria Key exclusion criteria |
|
| 5 | Update | 2024/03/26 05:16:46 | Recruitment status |
|
| 6 | Update | 2025/11/11 09:07:19 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 7 | Update | 2025/11/11 09:16:43 | Study type Basic design Randomization Randomization unit Blinding Control Dynamic allocation No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Interventions/Control_3 Key inclusion criteria Key inclusion criteria Target sample size |
|
| 8 | Update | 2025/11/11 09:19:12 | Last follow-up date |
|
| 9 | Update | 2025/11/11 10:03:49 | Narrative objectives1 Narrative objectives1 Basic objectives2 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 10 | Update | 2025/11/11 10:05:23 | Anticipated trial start date Other related information Other related information |
|
| 11 | Update | 2025/11/11 10:07:05 | Number of participants that the trial has enrolled |
|
| 12 | Update | 2025/11/11 10:20:04 | Organization Organization Organization Category of Funding Organization |
|
| 13 | Update | 2025/11/11 10:21:55 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 14 | Update | 2025/11/11 10:24:49 | Target sample size |
|
| 15 | Update | 2025/11/11 10:26:05 | Last follow-up date |
|
| 16 | Update | 2025/11/11 10:29:37 | Anticipated trial start date |